Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
First Claim
1. A composition for coating a surgically acceptable patch comprised of:
- (a) a hydrophilic polymer;
(b) polyethylene glycol functionalized with m thiol groups, wherein m≧
2;
(c) polyethylene glycol functionalized with n succinimidyl groups, wherein n≧
2 and m+n≧
4; and
(d) a platelet derived growth factor,wherein crosslinking of the composition upon contact with moisture results in a biocompatible, crosslinked matrix.
5 Assignments
0 Petitions
Accused Products
Abstract
Crosslinkable compositions are provided that readily crosslink in situ to provide biocompatible, nonimmunogenic crosslinked materials that may be used as adhesive compositions. The compositions comprise collagen and a plurality of crosslinkable components having reactive functional groups thereon, with the functional groups selected so as to enable inter-reaction between the components, i.e., crosslinking. Methods for preparing and using the compositions are also provided. Exemplary uses include tissue augmentation, biologically active agent delivery, bioadhesion, prevention of adhesions following surgery or injury, and coating of surgically acceptable patches and solid implants, the latter including sutures.
-
Citations
13 Claims
-
1. A composition for coating a surgically acceptable patch comprised of:
-
(a) a hydrophilic polymer; (b) polyethylene glycol functionalized with m thiol groups, wherein m≧
2;(c) polyethylene glycol functionalized with n succinimidyl groups, wherein n≧
2 and m+n≧
4; and(d) a platelet derived growth factor, wherein crosslinking of the composition upon contact with moisture results in a biocompatible, crosslinked matrix. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 12)
-
-
10. A coated device comprising:
-
a surgically acceptable patche; a coating composition on the surgically acceptable patch formed by crosslinking; (a) polyethylene glycol functionalized with m thiol groups, wherein m≧
2;(b) polyethylene glycol functionalized with n succinimidyl groups, wherein n≧
2 and m+n≧
4; and(c) a platelet derived growth factor. - View Dependent Claims (11, 13)
-
Specification